Advancing early detection of neurodegenerative disease.
We develop clinically validated diagnostic tests that help physicians identify Alzheimer's, Parkinson's, and ALS earlier. Precision diagnostics for better patient outcomes.
Building precision diagnostics for neurodegenerative disease detection
Vivid Genomics was founded to address a critical gap in neurodegenerative disease diagnosis. We developed clinically validated assays that help physicians detect Alzheimer's, Parkinson's, and ALS earlier, when intervention can make the greatest difference. Our work bridges laboratory science and patient care.
The Scientists Behind Vivid Genomics
Our team combines deep expertise in molecular diagnostics and neurodegenerative disease research with a shared commitment to advancing early detection and patient care.
Founder and Chief Scientific Officer
Dr. Michael Richardson
Michael leads Vivid Genomics' scientific vision. His background in molecular diagnostics and neurodegenerative disease research drives our commitment to clinically validated assays that support early detection and advance patient outcomes.
Senior Assay Development Scientist
Dr. Priya Mehta
Priya specializes in developing and validating diagnostic assays for Alzheimer's, Parkinson's, and ALS. Her expertise ensures our tests meet the highest standards of accuracy and clinical reliability for physicians and patients.
Quality and Regulatory Affairs Manager
James Chen
James ensures Vivid Genomics' diagnostics meet rigorous regulatory standards and quality requirements. His work keeps our assays compliant and clinically trusted across diagnostic laboratories in San Diego and beyond.
Head of Clinical Partnerships
Dr. Isabella Ruiz
Isabella builds relationships between Vivid Genomics and healthcare providers, researchers, and clinicians. She ensures our diagnostic tools reach physicians who need them to support better patient care and advance neurodegenerative disease research.
Advancing Neurodegenerative Disease Detection
Vivid Genomics is committed to developing clinically validated diagnostic assays that help physicians identify and understand neurodegenerative diseases earlier.
3
Neurodegenerative diseases
We develop diagnostic assays for Alzheimer's, Parkinson's, and ALS to support early detection.
100%
Clinical validation focus
Every test we create undergoes rigorous validation to ensure accuracy and reliability for physicians.
San Diego
Research hub location
Based in California, Vivid Genomics advances diagnostic science and patient care innovation.
24/7
Support availability
We're here to answer questions about our tests and support your diagnostic needs anytime.
Physicians and researchers relying on Vivid Genomics
Healthcare providers and research institutions depend on our clinically validated assays for accurate early detection and disease understanding.
Vivid Genomics' assays have significantly improved our diagnostic accuracy for early Alzheimer's detection. The clinical validation and reliability give us confidence in patient outcomes.
Dr. Robert Martinez
Neurologist, San Diego Memory Care Center
Working with Vivid Genomics transformed how we approach ALS research. Their precise biomarker assays enabled breakthroughs in our clinical studies that weren't possible before.
Dr. Sarah Chen
Research Director, UC San Diego Neuroscience Institute
The support from Vivid Genomics goes beyond the tests themselves. Their team understands what we need as clinicians and continuously improves their assay performance.
Dr. James Wilson
Movement Disorders Specialist, Coastal Neurology Group
Vivid Genomics delivers the accuracy and reproducibility our Parkinson's research demands. Their technical expertise and responsiveness set them apart in this field.
Dr. Elena Rossi
Principal Investigator, Parkinson's Research Consortium
As a diagnostic laboratory, we trust Vivid Genomics' assays completely. Their commitment to clinical validation and quality is exactly what we need for patient care.
Dr. Michael Park
Laboratory Director, Regional Diagnostic Center
Ready to explore our diagnostic solutions?
Learn how Vivid Genomics' clinically validated assays support early detection and advance patient care.